Further, to validate the correlated expression of EZH2 targets and EZH2 in conditions such as nicotine consumption, we performed immunohistochemistry with SUMF1, the target showing most significant association with breast cancer patient survival, in tissue sections of smoking and non-smoking breast tumors. Here, SUMF1 is linked to breast cancer.